Articles tagged "Safety"

2019 American Transplant Congress
Outcomes for Liver Transplant Recipients on Renal Replacement Therapy: Who Cannot Wait for Safety Net
A. Pita¹, N. Kaur¹, M. Lo², A. F. Sabour¹, V. Tristan¹, Y. Genyk¹, M. K. Nadim³, L. Sher¹
¹Department of Surgery, Keck Medical Center of USC, Los Angeles, CA, ²Department of Preventive Medicine, Keck Medical Center of USC, Los Angeles, CA, ³Department of Medicine, Keck Medical Center of USC, Los Angeles, CA
*Purpose: The purpose of this study is to identify risk factors for poor outcomes for liver transplant (LT) recipients on renal replacement therapy (RRT) in…
2019 American Transplant Congress
Page Kidney Phenomenon in a Trauma Patient: A Case Report and Recommendations for Management
M. M. Estrada, D. R. Hall, W. Dar, J. S. Bynon
University of Texas Health Science Center at Houston, Houston, TX
*Purpose: Unintentional injuries result in over 30 million emergency room visits annually in the United States. With almost 20 thousand renal transplants performed in 2017,…
2019 American Transplant Congress
Comparable Outcomes of Deceased Donor Liver Transplant Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis
H. Sharma, H. Bohorquez, D. Oganesyan, D. Bruce, E. Bugeaud, I. Carmody, A. Cohen, J. Seal, D. Sonnier, G. Loss
Department of Transplant Surgery, Ochsner Medical Center, New Orleans, LA
*Purpose: Few studies have evaluated the impact of previous abdominal surgery (PAS) on deceased donor liver transplantation-(DDLT). Furthermore, there is no evidence of impact of…
2019 American Transplant Congress
Safety and Efficacy of Anti Xa Inhibitors Post-Transplant with Concomitant Calcineurin Inhibitors
K. A. McMurry¹, J. Shuster², K. Bain², T. Horwedel³, J. Hartupee²
¹Michigan Medicine, Ann Arbor, MI, ²Barnes-Jewish Hospital, St. Louis, MO, ³Veloxis Pharmaceuticals, Cary, NC
*Purpose: Despite demonstrated benefits of Anti-Xa Inhibitors (ATIs) in the general population, ATIs have not gained uniform acceptance in SOT due to lack of supportive…
2019 American Transplant Congress
Donor Derived Tuberculosis in Solid Organ Transplantation in the United States: 10 Years of UNOS Ad Hoc Disease Transmission Advisory Committee Experience
M. F. Malinis¹, R. LaHoz¹, G. Vece², S. Tlusty², S. Aslam¹, R. Bag¹, J. Bucio¹, L. Danziger-Isakov¹, D. F. Florescu¹, M. Rana¹, C. Wolfe¹, M. G. Michaels¹
¹DTAC, Richmond, VA, ²UNOS, Richmond, VA
*Purpose: Mycobacterium tuberculosis can be transmitted via organ donation. Failure to recognize tuberculosis (TB) may result in significant morbidity and mortality. Currently, donor screening for…
2019 American Transplant Congress
Direct Oral Anticoagulants: An Evaluation of the Safety and Efficacy in Solid Organ Transplant Recipients
T. Pasley, A. Logan, A. Brueckner, L. Bowman, A. Silverman, A. Rumore
Tampa General Hospital, Tampa, FL
*Purpose: The use of direct oral anticoagulants (DOACs) has not been fully adopted by the solid organ transplant (SOT) community due to factors including, fluctuating…
2019 American Transplant Congress
Real-Life Food Safety Behavior and Incidence of Food-Borne Infections in Solid-Organ Transplant Recipients
M. Lindup, D. Golshayan, M. Pascual, O. Manuel, M. Mombelli
CHUV, Lausanne, Switzerland
*Purpose: Specific food safety measures are highly recommended in solid-organ transplant (SOT) recipients. However, the actual adherence of patients in real life and the impact…
2019 American Transplant Congress
The Incidence of Fungal Infections in Pancreas Transplant Recipients in the Absence of Systemic Antifungal Prophylaxis
S. Shaikh¹, M. Cooper¹, A. Nolan¹, P. Abrams²
¹MedStar Georgetown University Hospital, Washington, DC, ²MedStar Gerogetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Fungal infections after pancreas transplantation have been associated with morbidity and mortality, therefore transplant centers may elect to use systemic perioperative antifungal prophylaxis (ppx).…
2019 American Transplant Congress
Torque Teno Virus is a Prognostic Biomarker for Acute Biopsy-Proven Alloreactivity in Kidney Transplants
K. Doberer
Dpt. of Internal Medicine III, Div. of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria
*Purpose: Drug-induced immunosuppression in kidney transplantation is crucial to prevent allograft rejection, but increases risk for infectious, cardiovascular and malignant disease. Tailoring of immunosuppressive drug…
2019 American Transplant Congress
Whole Body CT Imaging in Deceased Donor Screening
J. W. Mensink¹, R. A. Pol.², W. N. Nijboer¹, J. de Jonge³, K. M. Ooms - de Vries⁴, M. F. van der Jagt⁵, M. C. van de Poll⁶, I. P. Alwayn¹, A. E. Braat¹
¹Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, ²Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands, ³Department of Surgery; Division of Transplantation, Erasmus Medical Center, Rotterdam, Netherlands, ⁴Dutch Transplant Foundation, Leiden, Netherlands, ⁵Department of Surgery; Division of Transplantation, University Medical Center St. Radboud, Nijmegen, Netherlands, ⁶Department of Surgery and Department of Intensive Care, Maastricht University Medical Center, Maastricht, Netherlands
*Purpose: Using older (extended criteria) donors to increase the donor pool increases the risk of malignancies in the donor. Our aim was to analyze the…